We are monitoring the impact of COVID-19 on Latin America Companion Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 592
Share on
Share on

Latin America Companion Diagnostics Market Research Report – Segmented By Indication, By Technology & By Country (Mexico, Brazil, Argentina, Chile and Rest of Latin America) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2021 to 2026)

Pulished: April, 2021
ID: 592
Pages: 145

Latin American Companion Diagnostics Market Size (2021 to 2026)

As per our report, the size of the Latin American Companion Diagnostics Market was worth USD 0.33 billion in 2021 and estimated to be growing at a CAGR of 22.83%, to reach USD 0.93 billion by 2026.

Increasing clinical trials to improve cancer patient diagnosis & treatment in Latin America is a significant factor propelling the market's demand. In addition, the increased adoption of innovative medical procedures, the rising disposable incomes of consumers, and the increasing healthcare infrastructure will fuel the Latin America companion diagnostics market.

Companion diagnostics are in-vitro diagnostics that deliver information about the therapeutic reactions of patients for a specific treatment. Companion diagnostics is a comparatively new branch of diagnostics that is predicted to grow rapidly in the near future. The various advantages it offers have increased its market demand. Companion diagnostics are widely used in lung cancer, breast cancer, etc., to detect cancer mutation. According to WHO, approximately 15 % of cancers were diagnosed in 2012 in low & middle-income countries and 9.6 million deaths in 2018 globally. In 2018, the US Food & Drug Administration published the guidelines for Developing & labeling In Vitro Companion Diagnostic devices for a specific group or classes of oncology therapeutic products. 

Increasing demand for personalized medicines, rising occurrence of cancer, and reducing costs of drug development are the key factors fuelling the market's growth for companion diagnostics. Factors such as the growing emphasis on targeted therapies and the attention of pharmaceutical companies on the in-house development of companion diagnostics are also enhancing the market's growth. However, the increasing period of the approval process and the extended development time of companion diagnostics may obstruct the market's growth.

This research report on the Latin American Companion Diagnostics Market has been segmented and sub-segmented into the following categories:

By Indications:

  • Oncology
    • Colorectal Cancer
    • Lung Cancer
    • Breast Cancer
    • Gastric Cancer
    • Melanoma
  • Inflammation and Autoimmune Diseases
  • Cardiovascular Diseases
  • Central Nervous System Disorders
  • Virology Diseases

By Technology:

  • Immunohistochemistry
  • Molecular Diagnostics
    • In-Situ Hybridization
    • Real-Time PCR
    • Gene Sequencing

By Country: 

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

Regionally, the Mexican companion diagnostics market is predicted to dominate the Latin American market and is estimated to continue its dominance during the forecast period.

The Brazilian companion diagnostics market can adopt a new precise medicine & companion diagnostic market than other Latin American countries. Government collaborates with private organizations, research institutes & hospitals for companion diagnostics. Brazil increases its companion diagnostic market by entering into the medical field.  Brazil is one of the fastest-growing countries in Latin America due to the potential benefits of companion diagnostic & medicine. Growing molecular pathology & diagnostic technology can boost market growth.

The companion diagnostics market is estimated to exhibit healthy CAGR during the forecast period. Increasing government initiatives for developing a companion diagnostic market are dominating the growth of the Argentina companion diagnostics market. Key market players are focusing on collaboration & strategic acquisition to raise their market value.

The rising number of chronic diseases in the country is fuelling the demand for companion diagnostic tests. Expected need for in vitro diagnostic test adding fuel into Chile companion diagnostic market.

KEY MARKET PLAYERS:

Some of the prominent companies operating in the Latin American companion diagnostics market profiled in this report are Abbott Molecular Inc., Roche Molecular Systems Inc., Leica Biosystems Nussloch GmbH, bioMérieux Inc., Dako Inc., Qiagen Ltd., ARUP Laboratories, Myriad Genetics Inc., Biogenex Laboratories Inc., Ventana Medical Systems Inc., and Thermo Fisher Scientific Inc.

  1. 1. Introduction                                 

                    1.1 Market Definition                    

                    1.2 Study Deliverables                  

                    1.3 Base Currency, Base Year and Forecast Periods                          

                    1.4 General Study Assumptions                

    2. Research Methodology                                           

                    2.1 Introduction                               

                    2.2 Research Phases                      

                                    2.2.1 Secondary Research           

                                    2.2.2 Primary Research 

                                    2.2.3 Econometric Modelling      

                                    2.2.4 Expert Validation  

                    2.3 Analysis Design                         

                    2.4 Study Timeline                          

    3. Overview                                       

                    3.1 Executive Summary                

                    3.2 Key Inferences                         

                    3.3 New Developments                               

    4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                    4.1 Market Drivers                          

                    4.2 Market Restraints                    

                    4.3 Key Challenges                         

                    4.4 Current Opportunities in the Market                              

    5. Market Segmentation                                              

                    5.1 By Indications                            

                                    5.1.1 Oncology 

                                                    5.1.1.1 Colorectal Cancer

                                                    5.1.1.2 Breast Cancer

                                                    5.1.1.3 Lung Cancer

                                                    5.1.1.4 Gastric Cancer

                                                    5.1.1.5 Melanoma

                                    5.1.2 Inflammation and Autoimmune Diseases  

                                    5.1.3 Cardiovascular Diseases    

                                    5.1.4 Central Nervous System Disorders               

                                    5.1.5 Virology Diseases 

                    5.2 By Technology                           

                                    5.2.1 Immuno Histochemistry    

                                    5.2.2 Molecular Diagnostics        

                                                    5.2.2.1 In-Situ Hybridization

                                                    5.2.2.2 Real Time PCR

                                                    5.2.2.3 Gene Sequencing

    6. Geographical Analysis                                              

                                    6.1 Introduction               

                                    6.2 Brazil             

                                    6.3 Mexico         

                                    6.4 Argentina    

                                    6.5 Rest of Latin America             

    7. Strategic Analysis                                       

                    7.1 PESTLE analysis                         

                                    7.1.1 Political     

                                    7.1.2 Economic 

                                    7.1.3 Social         

                                    7.1.4 Technological         

                                    7.1.5 Legal          

                                    7.1.6 Environmental       

                    7.2 Porter’s Five analysis                              

                                    7.2.1 Bargaining Power of Suppliers        

                                    7.2.2 Bargaining Power of Consumers    

                                    7.2.3 Threat of New Entrants     

                                    7.2.4 Threat of Substitute Products and Services              

                                    7.2.5 Competitive Rivalry within the Industry     

    8. Market Leaders' Analysis                                        

                    8.1 Abbott Molecular Inc.                            

                                    8.1.1 Overview 

                                    8.1.2 Product Analysis   

                                    8.1.3 Strategic Evaluation and Operations            

                                    8.1.4 Financial analysis  

                                    8.1.5 Legal issues             

                                    8.1.6 Recent Developments       

                                    8.1.7 SWOT analysis       

                                    8.1.8 Analyst View          

                    8.2 Roche Molecular Systems Inc.                            

                    8.3 Leica Biosystems Nussloch GmbH                     

                    8.4 BioMérieux Inc.                        

                    8.5 Dako Inc.                     

                    8.6 Qiagen Ltd.                 

                    8.7 ARUP Laboratories                  

                    8.8 Myriad Genetics Inc.                              

                    8.9 Biogenex Laboratories, Inc.                 

                    8.10 Ventana Medical Systems Inc.                         

                    8.11 Thermo Fisher Scientific Inc.                             

    9. Competitive Landscape                                           

                    9.1 Market share analysis                            

                    9.2 Merger and Acquisition Analysis                       

                    9.3 Agreements, collaborations and Joint Ventures                         

                    9.4 New Product Launches                         

    10. Expert Opinions                                        

                    10.1 Market Outlook                     

                    10.2 Investment Opportunities                 

    Appendix                                           

                    a) List of Tables                

                    b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Latin America Companion Diagnostics Market By Region, From 2021 to 2026 (USD Billion)
  2. Latin America Companion Diagnostics Market By Indication, From 2021 to 2026 (USD Billion)
  3. Latin America Oncology Market By Region, From 2021 to 2026 (USD Billion)
  4. Latin America Inflammation and Autoimmune Diseases Market By Region, From 2021 to 2026 (USD Billion)
  5. Latin America Cardiovascular Diseases Market By Region, From 2021 to 2026 (USD Billion)
  6. Latin America Central Nervous System Disorders Market By Region, From 2021 to 2026 (USD Billion)
  7. Latin America Virology Diseases Market By Region, From 2021 to 2026 (USD Billion)
  8. Latin America Companion Diagnostics Market By Technology, From 2021 to 2026 (USD Billion)
  9. Latin America Immuno Histochemistry Market By Region, From 2021 to 2026 (USD Billion)
  10. Latin America Molecular Diagnostics Market By Region, From 2021 to 2026 (USD Billion)
  11. Latin America Oncology Diagnostics Market By Type, From 2021 to 2026 (USD Billion)
  12. Latin America Colorectal Cancer Diagnostics Market By Region, From 2021 to 2026 (USD Billion)
  13. Latin America Breast Cancer Diagnostics Market By Region, From 2021 to 2026 (USD Billion)
  14. Latin America Lung Cancer Diagnostics Market By Region, From 2021 to 2026 (USD Billion)
  15. Latin America Gastric Cancer Diagnostics Market By Region, From 2021 to 2026 (USD Billion)
  16. Latin America Melanoma Diagnostics Market By Region, From 2021 to 2026 (USD Billion)
  17. Latin America Molecular Diagnostics Market By Type, From 2021 to 2026 (USD Billion)
  18. Latin America In-Situ Hybridization Market By Region, From 2021 to 2026 (USD Billion)
  19. Latin America Real Time PCR Market By Region, From 2021 to 2026 (USD Billion)
  20. Latin America Gene Sequencing Market By Region, From 2021 to 2026 (USD Billion)
  21. Brazil Companion Diagnostics Market By Indication, From 2021 to 2026 (USD Billion)
  22. Brazil Companion Diagnostics Market By Technology, From 2021 to 2026 (USD Billion)
  23. Brazil Oncology Diagnostics Market By Type, From 2021 to 2026 (USD Billion)
  24. Brazil Molecular Diagnostics Market By Type, From 2021 to 2026 (USD Billion)
  25. Argentina Companion Diagnostics Market By Indication, From 2021 to 2026 (USD Billion)
  26. Argentina Companion Diagnostics Market By Technology, From 2021 to 2026 (USD Billion)
  27. Argentina Oncology Diagnostics Market By Type, From 2021 to 2026 (USD Billion)
  28. Argentina Molecular Diagnostics Market By Type, From 2021 to 2026 (USD Billion)
  29. Mexico Companion Diagnostics Market By Indication, From 2021 to 2026 (USD Billion)
  30. Mexico Companion Diagnostics Market By Technology, From 2021 to 2026 (USD Billion)
  31. Mexico Oncology Diagnostics Market By Type, From 2021 to 2026 (USD Billion)
  32. Mexico Molecular Diagnostics Market By Type, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample